查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1592032

關節止痛注射市場：按注射類型、關節類型、分銷管道分類 - 全球預測 2025-2030

Joint Pain Injections Market by Injection Type (Corticosteroid Injections, Hyaluronic Acid Injections), Joint Type (Facet Joints of the Spine, Hip Joint, Knee & Ankle), Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年關節止痛注射市場價值為45.5億美元，預計到2024年將達到50.4億美元，複合年成長率為10.94%，到2030年將達到94.2億美元。

關節疼痛注射是一種重要的醫療干預措施，旨在緩解患有各種關節相關疾病（例如關節炎和其他退化性疾病）的患者的不適並改善活動能力。這些注射涵蓋多種產品，包括皮質類固醇、透明質酸和其他生物注射。需要的是能夠提供有針對性的緩解，特別是當內服藥物和物理治療不足時，透過直接作用於發炎和疼痛。關節疼痛注射的應用多種多樣，包括整形外科診所、醫院和專門的疼痛管理中心，主要服務於老齡化人口和患有運動相關損傷的人。最終用途包括老年病學、風濕病學、運動醫學等。

主要市場統計
基準年[2023] 45.5億美元
預測年份 [2024] 50.4億美元
預測年份 [2030] 94.2億美元
複合年成長率（%） 10.94%

關節痛注射劑市場受到慢性關節疾病盛行率不斷上升、製劑技術進步以及微創治療需求不斷增加等因素的顯著影響。潛在的機會包括再生細胞療法等新型注射劑的開發以及先進醫療保健機會迅速增加的新興經濟體的市場開拓。為了保持競爭力，公司應專注於與醫療保健提供者和研究機構合作，以促進創新並擴大產品系列。然而，市場面臨一些限制，例如與先進注射療法相關的高成本以及減緩產品上市的嚴格法規環境。此外，患者對非侵入性替代療法的偏好對市場成長構成了挑戰。

前景廣闊的創新研發領域包括開發更持久的配方、基於基因分析的個人化注射療法，以及整合數位健康解決方案以有效監測治療結果。市場是動態的，其特點是技術快速進步和新進入者，加劇了競爭，同時也促進了創新。為了抓住這些機會，公司必須投資研發，優先考慮策略夥伴關係關係，並維持遵守監管標準，以利用不斷變化的環境並滿足醫療保健產業的複雜需求。

市場動態：快速發展的關節止痛注射市場的關鍵市場洞察

供需的動態交互作用正在改變關節止痛注射市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 全球關節疾病盛行率不斷上升
    • 類風濕性關節炎、骨關節炎、脊椎疾病和嚴重四肢創傷的發生率增加
    • 政府機構提供意識計劃
  • 市場限制因素
    • 關節疼痛注射高成本
  • 市場機會
    • 骨關節炎疼痛治療的進展
    • 提高對關節內注射益處的認知
  • 市場挑戰
    • 缺乏注射意識

波特五力：駕馭關節止痛注射市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解外部對關節疼痛注射劑市場的影響

外部宏觀環境因素在塑造關節疼痛注射劑市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解關節止痛注射劑市場的競爭狀況

關節疼痛注射市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的見解，以應對日益激烈的競爭。

FPNV 定位矩陣關節疼痛注射市場供應商的績效評估

FPNV定位矩陣是評估關節疼痛注射劑市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了關節疼痛注射市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對關節疼痛注射市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地關節疾病的盛行率正在增加。
      • 類風濕性關節炎、骨關節炎、脊椎疾病和嚴重四肢創傷的病例增加
      • 政府機構提供的意識計劃
    • 抑制因素
      • 注射治療關節疼痛的費用很高。
    • 機會
      • 骨關節炎疼痛治療的進展
      • 提高對關節內注射益處的認知
    • 任務
      • 缺乏注射意識
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章依注射類型分類的關節痛注射劑市場

  • 皮質類固醇注射
  • 玻尿酸注射

第7章按關節類型分類的關節止痛注射市場

  • 脊椎的椎間關節
  • 髖關節
  • 膝蓋和腳踝
  • 肩膀和肘部

第8章關節止痛注射市場：依通路分類

  • 醫院藥房
  • 網路藥房
  • 零售藥房

第9章 北美、南美關節疼痛注射市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區關節止痛注射市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東、非洲關節疼痛注射市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Anika Therapeutics, Inc.
  • Asterisk Laboratories（I）Pvt. Ltd.
  • Bioventus LLC
  • Chugai Pharmaceutical Co., Ltd.
  • Ferring BV
  • Henry Schein, Inc.
  • Hetero Healthcare Limited
  • Krosyl Pharmaceuticals Pvt. Ltd.
  • Medilink Pharma
  • Pfizer Inc.
  • Salavidas Pharmaceutical Pvt. Ltd.
  • Sanofi SA
  • Seikagaku Corporation
  • TEENA LABS LTD
  • Wellona Pharma
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-43470FC6083D

The Joint Pain Injections Market was valued at USD 4.55 billion in 2023, expected to reach USD 5.04 billion in 2024, and is projected to grow at a CAGR of 10.94%, to USD 9.42 billion by 2030.

Joint pain injections are a critical healthcare intervention aimed at alleviating discomfort and improving mobility for individuals suffering from various joint-related ailments, such as arthritis and other degenerative conditions. These injections encompass a broad range of products, including corticosteroids, hyaluronic acid, and other biological injectables. Their necessity arises from their ability to provide targeted relief in cases where oral medications or physical therapies may be insufficient, particularly in addressing inflammation and pain directly at the site. The application of joint pain injections spans orthopedic clinics, hospitals, and specialized pain management centers, catering mainly to an aging population and individuals with sports-related injuries. The end-use scope broadly includes geriatric care, rheumatology, and sports medicine.

KEY MARKET STATISTICS
Base Year [2023] USD 4.55 billion
Estimated Year [2024] USD 5.04 billion
Forecast Year [2030] USD 9.42 billion
CAGR (%) 10.94%

The market for joint pain injections is significantly influenced by factors such as increasing prevalence of chronic joint conditions, advancements in formulation technologies, and a rising demand for minimally invasive treatments. Potential opportunities lie in the development of novel injectables, like regenerative cell therapies, and expanding geographic markets in emerging economies, where access to advanced medical treatments is burgeoning. Companies should focus on collaborations with healthcare providers and research institutions to foster innovation and expand their product portfolios to stay competitive. However, the market faces limitations such as high costs associated with advanced injectable therapies and stringent regulatory environments that can delay product launches. Additionally, patient preference for non-invasive alternatives presents a challenge to market growth.

Innovation and research areas that present promising prospects include the development of longer-lasting formulations, personalization of injectable therapies based on genetic profiling, and integration of digital health solutions to monitor treatment outcomes effectively. The market is dynamic, characterized by rapid technological advancements and the entry of new players, which intensifies competition but also drives innovation. To seize these opportunities, businesses should invest in R&D, prioritize strategic partnerships, and maintain compliance with regulatory standards to harness the evolving landscape and meet the intricate demands of the healthcare sector.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Joint Pain Injections Market

The Joint Pain Injections Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of joint disorders across globe
    • Rising cases of rheumatoid arthritis, osteoarthritis, spinal disorders, and severe limb trauma
    • Availability of awareness programs by government organizations
  • Market Restraints
    • High cost of the joint pain injections
  • Market Opportunities
    • Advancement in osteoarthritis pain treatment
    • Growing awareness about benefits of intra-articular injections
  • Market Challenges
    • Lack of awareness regarding injections

Porter's Five Forces: A Strategic Tool for Navigating the Joint Pain Injections Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Joint Pain Injections Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Joint Pain Injections Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Joint Pain Injections Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Joint Pain Injections Market

A detailed market share analysis in the Joint Pain Injections Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Joint Pain Injections Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Joint Pain Injections Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Joint Pain Injections Market

A strategic analysis of the Joint Pain Injections Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Joint Pain Injections Market, highlighting leading vendors and their innovative profiles. These include Anika Therapeutics, Inc., Asterisk Laboratories (I) Pvt. Ltd., Bioventus LLC, Chugai Pharmaceutical Co., Ltd., Ferring B.V., Henry Schein, Inc., Hetero Healthcare Limited, Krosyl Pharmaceuticals Pvt. Ltd., Medilink Pharma, Pfizer Inc., Salavidas Pharmaceutical Pvt. Ltd., Sanofi S.A., Seikagaku Corporation, TEENA LABS LTD, Wellona Pharma, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Joint Pain Injections Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Injection Type, market is studied across Corticosteroid Injections and Hyaluronic Acid Injections.
  • Based on Joint Type, market is studied across Facet Joints of the Spine, Hip Joint, Knee & Ankle, and Shoulder & Elbow.
  • Based on Distribution Channel, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of joint disorders across globe
      • 5.1.1.2. Rising cases of rheumatoid arthritis, osteoarthritis, spinal disorders, and severe limb trauma
      • 5.1.1.3. Availability of awareness programs by government organizations
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of the joint pain injections
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancement in osteoarthritis pain treatment
      • 5.1.3.2. Growing awareness about benefits of intra-articular injections
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of awareness regarding injections
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Joint Pain Injections Market, by Injection Type

  • 6.1. Introduction
  • 6.2. Corticosteroid Injections
  • 6.3. Hyaluronic Acid Injections

7. Joint Pain Injections Market, by Joint Type

  • 7.1. Introduction
  • 7.2. Facet Joints of the Spine
  • 7.3. Hip Joint
  • 7.4. Knee & Ankle
  • 7.5. Shoulder & Elbow

8. Joint Pain Injections Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Hospital Pharmacies
  • 8.3. Online Pharmacies
  • 8.4. Retail Pharmacies

9. Americas Joint Pain Injections Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Joint Pain Injections Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Joint Pain Injections Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Anika Therapeutics, Inc.
  • 2. Asterisk Laboratories (I) Pvt. Ltd.
  • 3. Bioventus LLC
  • 4. Chugai Pharmaceutical Co., Ltd.
  • 5. Ferring B.V.
  • 6. Henry Schein, Inc.
  • 7. Hetero Healthcare Limited
  • 8. Krosyl Pharmaceuticals Pvt. Ltd.
  • 9. Medilink Pharma
  • 10. Pfizer Inc.
  • 11. Salavidas Pharmaceutical Pvt. Ltd.
  • 12. Sanofi S.A.
  • 13. Seikagaku Corporation
  • 14. TEENA LABS LTD
  • 15. Wellona Pharma
  • 16. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. JOINT PAIN INJECTIONS MARKET RESEARCH PROCESS
  • FIGURE 2. JOINT PAIN INJECTIONS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. JOINT PAIN INJECTIONS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. JOINT PAIN INJECTIONS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. JOINT PAIN INJECTIONS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. JOINT PAIN INJECTIONS MARKET DYNAMICS
  • TABLE 7. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROID INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY FACET JOINTS OF THE SPINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY HIP JOINT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY KNEE & ANKLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY SHOULDER & ELBOW, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 146. JOINT PAIN INJECTIONS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. JOINT PAIN INJECTIONS MARKET, FPNV POSITIONING MATRIX, 2023